|
USP30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.310200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.891000E-01 |
| Normal-vs-Stage2 |
5.449600E-02 |
| Normal-vs-Stage3 |
1.623700E-04 |
| Normal-vs-Stage4 |
9.039600E-04 |
| Stage1-vs-Stage2 |
1.764100E-02 |
| Stage1-vs-Stage3 |
2.04879999998742E-06 |
| Stage1-vs-Stage4 |
4.41970000000236E-05 |
| Stage2-vs-Stage3 |
3.103200E-01 |
| Stage2-vs-Stage4 |
3.184600E-01 |
| Stage3-vs-Stage4 |
9.064200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.449600E-02 |
| Normal-vs-AfricanAmerican |
8.412100E-02 |
| Normal-vs-Asian |
4.498600E-01 |
| Caucasian-vs-AfricanAmerican |
3.759600E-01 |
| Caucasian-vs-Asian |
9.544400E-01 |
| AfricanAmerican-vs-Asian |
7.968600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.062600E-03 |
| Normal-vs-Female |
9.952200E-01 |
| Male-vs-Female |
2.024600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.343600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.073600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.504300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.568800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.065040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.231200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.953600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.746300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.921200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.973400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.718300E-02 |
| Normal-vs-Grade 2 |
4.589600E-01 |
| Normal-vs-Grade 3 |
3.877900E-03 |
| Normal-vs-Grade 4 |
7.28900051427672E-10 |
| Grade 1-vs-Grade 2 |
3.962400E-02 |
| Grade 1-vs-Grade 3 |
2.406200E-04 |
| Grade 1-vs-Grade 4 |
7.72339999732807E-08 |
| Grade 2-vs-Grade 3 |
7.98180000000093E-05 |
| Grade 2-vs-Grade 4 |
2.11870521127366E-11 |
| Grade 3-vs-Grade 4 |
2.19830000000032E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.184400E-02 |
| Normal-vs-ccB subtype |
2.43099999999163E-05 |
| ccA subtype-vs-ccB subtype |
1.87569959564371E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.944400E-01 |
| Normal-vs-N1 |
1.162170E-03 |
| N0-vs-N1 |
1.257420E-03 |
|
|
